OBJECTIVE:To establish the quality standard of Paris pubescens. METHODS:Qualitative identification of medici-nal material was conducted from original plant morphology,properties and microscopic characteristics (cross section,powder). The contents of parissaponinⅠ,Ⅱ,Ⅵ,Ⅶwere determined by HPLC. The determination was performed on Agilent C18 column with mobile phase consisted of acetonitrile-water(gradient elution)at the flow rate of 0.9 mL/min. The detection wavelength was set at 203 nm,and column temperature was 25 ℃. The sample size was 5 μL. The content of total saponins in P. pubescens was deter-mined by UV spectrophotometry. RESULTS:The rhizome of P. pubescens was nodular flat cylindrical in shape,slightly curved,ti-ny odor,bitter in taste. The large vessels were found in transverse xylem;phloem cells were small;powder had a large number of starch grains,mostly single grain. The linear ranges of parissaponin Ⅰ,Ⅱ,Ⅵ,Ⅶ and total saponins were 0.64-12.8,0.46-9.2, 0.26-5.2,0.23-4.6,20.5-143.5 μg(r were 0.9999、0.9999、0.9999、0.9999、0.9997),respectively. RSDs of precision,stability and reproducibility tests were all lower than 3.0%.The recoveries were 96.38%-105.24%(RSD=3.01%,n=6),97.24%-102.57%(RSD=2.50%,n=6),97.19%-101.74%(RSD=1.52%,n=6),93.72%-104.00%(RSD=3.53%,n=6),98.11%-104.50%(RSD=2.57%,n=6). CONCLUSIONS:Established standard can be used for quality evaluation of P. pubescens.

OBJECTIVE:To improve the determination method of Xiao'er resuqing oral solution in Chinese Pharmacopeia(2005 edition).METHODS:HPLC method was used to determine the content of baicalin.The separation was performed on Agilent zorbax SB-C18(150 mm?4.6 mm,5 ?m) column with methanol-water-phosphoric acid(45:55:0.2) as the mobile phase at flow rate of 1.0 mL?min-1.The detection wavelength was set at 276 nm.RESULTS:The linear range of baicalin was 0.5～100 ?g?mL-1(r=0.999 9) with an average recovery of 99.83%(RSD=0.99%,n=9).CONCLUSION:The method is rapid,convenient and accurate,and can be used as reference evidence for the content determination of Xiao'er resuqing oral solution in Chinese Pharmacopoeia(2005 edition).

OBJECTIVETo explore the species and distribution of medicinal plants Swertia in Yunnan province, and provide scientific basis for sustainable utilization.

METHODField investigation was carried out, specimens were collected, and literature and data were consulted.

RESULTThere were 35 species and 2 varieties (including 1 newly recorded species), most of them were used as medicinal plants, and an identification index was established.

CONCLUSIONThe results provide reliable foundation for comprehensive utilization and in-depth study of Swertia in Yunnan province.

China ; Conservation of Natural Resources ; Drugs, Chinese Herbal ; pharmacology ; therapeutic use ; Plants, Medicinal ; anatomy & histology ; chemistry ; classification ; growth & development ; Swertia ; anatomy & histology ; chemistry ; classification ; growth & development

OBJECTIVETo study the infection situation of arbuscular mycorrhizal fungi, as well as the mycorrhizal structures of Paris polyphylla var. yunnanensis, and the main types and quantities of AMF spores in rhizosphere soil.

METHODThe arbuscular mycorrhizal of P. polyphylla var. yunnanensis were detected by Phillips and Hayman staining. At the same time, some AMF spores were accessed by Gendemann's Wet-screening method and identified by their morphological characteristics.

RESULTArbuscular mycorrhizal fungi could infect the roots of P. polyphylla var. yunnanensis and formed arbuscular mycorrhizal. Infection rate was from 35.3% to 98.6%, indicating that infection strength was strong. From 10 soil samples collected in Yunnan, 11 Acaulospor species, 7 Glomus species, 3 Gigaspora species and 3 Scutellospora species were isolated and identified, including Acaulospora appendicola, A. brieticulata, A. excavata, A. foveata, A. lacunosa, A. laevis, A. koskei, A. myriocarpa, A. polonica, A. rehmii, A. scrobiculata, Glomus albidum, G. ambisporum, G. deserticola, G. fragarioides, G. luteum, G. microaggregatum, G. multiforum, Gigaspora albida, G. margarita, G. ramisporophora, Scutellospora calospora, S. pellucida and S. gilmorei. Among them, Acaulospora brieticulata was advantage species.

CONCLUSIONAMF may be a potent biological resource which can stimulate the growth of P. polyphylla var. yunnanensis.

Fungi ; isolation & purification ; physiology ; Magnoliopsida ; growth & development ; microbiology ; Mycorrhizae ; isolation & purification ; physiology ; Plant Roots ; growth & development ; microbiology ; Soil Microbiology

OBJECTIVE： To study the phylogenetic relationships of 3 basic plants of Tibetan medicine “Dida”， such as Swertia puricea， Wertia mileensis， Halenia elliptica. METHODS： ISSR technology was used for PCR amplification of 9 samples of S. puricea （ZT-1 to ZT-5 from Gantongsi in Dali Cangshan， ZC-1 to ZC-4 from Binchuan county of Dali）， 2 samples of W. mileensis （QYD-1 to QYD-2） and 2 samples of H. elliptica （HM-1 to HM-2）. Using DNA genome of S. puricea as template， 8 primers were screened and used for PCR reaction. The PCR amplification products were read by hand， the original data matrix was established， and the polymorphic band ratio was calculated. At the same time， genetic similarity coefficient was calculated by using NTSYS 2.1 software， and UPGMA method was used to draw cluster diagram. RESULTS： A total of 113 clear and identifiable amplification product bands were obtained by 8 ISSR primers. The rate of polymorphic site was 100％. The genetic similarity coefficients for totally 13 samples of S. puricea， W. mileensis and H. elliptica ranged 0.301-0.500. Intraspecific genetic similarity coefficients for 9 samples of S. puricea ranged from 0.752 to 0.929. The cluster analysis showed， when the range line was 0.410， 13 samples could be divided into three groups， i.e. S. puricea， W. mileensis， H. elliptica； when the range line was 0.780， 9 samples of S. purpurea could be divided into 2 subgroups， one of which was only sample ZT-1 collected from Gantongsi in Cangshan， and the other contained the remaining 8 samples. CONCLUSIONS： ISSR technology can be used to identify S. punicea， S. glabra and H. elliptica at the molecular level. S. punicea has some genetic relationship with S. glabra and H. elliptica， but the genetic relationship is relatively distant and the genetic difference is large. S. punicea from two different locations in Dali area has little genetic difference and close relationship， but it shows abundant genetic diversity.

OBJECTIVE：To study the spectrum-ef fect relationship of anti-hepatoma effect of C Ⅱ-3 extract from Periplaneta americana，and to preliminarily clarify the anti-hepatoma active components of it. METHODS ：Based on UHPLC fingerprints of 10 batches of C Ⅱ-3 samples，with the help of UHPL C-Q-TOF/MS，the compounds corresponding to each chromatographic peak were identified qualitatively by standard substances and related literatures. Using the IC 50 value of each batch of C Ⅱ-3 sample against human hepatoma cells HepG 2 as anti-hepatoma activity index ，the spectrum-effect relationship of fingerprint and anti-hepatoma effect was established and analyzed by the combination of grey relational analysis （GRA）and orthogonal partial least squares（OPLS）. RESULTS ：There were 25 common peaks in UHPLC fingerprints of 10 batches of C Ⅱ-3 samples，and 10 chemical compounds were identified ，which were cyclo- （Tyr-Pro）（peak 24），cyclo-（Gly-Phe）（peak 15），hypoxanthine（peak 3）， adenine（peak 7），phenylalanine（peak 10），inosine（peak 11），N-acetyldopamine（peak 16），cyclo-（Pro-Ala）（peak 13），2-hydroxy propionyl（peak 22），cyclo-（Pro-Ser）（peak 6）. The IC 50 of 10 batches of C Ⅱ-3 samples to HepG 2 cells was 70.550-200.303 μg/mL. Among 25 common peaks ，the order of GRA correlation （r）of anti-hepatoma activity was peak 20＞23＞24＞15，all of r values were greater than 0.7；the order of variable importance projection （VIP）of OPLS analysis was peak 23＞18＞15＞24＞7＞14＞6＞ 2＞20，all of VIP values were greater than 1. The standard regression coefficients of peak 7，15，20，23，24 were all greater than 0；while the standard regression coefficients of peak 2，6，14，18 were all less than 0. Conjoint analysis shows that the order of anti-hepatoma activity was peak 20＞23＞24＞15. CONCLUSIONS：unknown chemical ingredients （peak 20， ），cyclo-（Tyr-Pro）（peak 24）and cyclo- （Gly-Phe）（peak 15） in C Ⅱ-3 may be main anti-hepatoma active components.

OBJECTIVE：To systematically evaluate the occurren ce of non-immune related adverse events （AEs）caused by immune checkpoint inhibitors （ICIs）alone or combined with routine chemotherapy in the treatment of non-small cell lung cancer （NSCLC），and to provide evidence-based reference for clinical medication. METHODS ：Retrieved from PubMed ，Cochrane Library，Embase，CNKI，CBM，VIP and Wanfang database during the inception to Oct. 2020，randomized controlled trials （RCT） about ICIs alone or combined with routine chemotherapy （trial group ）versus routine chemotherapy or placebo combined with routine chemotherapy （control group ） were collected. After literature screening and data extraction ，the quality of included literatures were evaluated with bias risk evaluation tool recommended by Cochrane systematic evaluator manual 5.1.0. Meta-analysis was performed by using Rev Man 5.3 software and Stata 15.0 software. Sensitivity analysis was conducted with Stata 15.0 software. Inverted funnel plot and Egger ’s test were used to analyze publication bias. RESULTS ：A total of 20 RCTs were included ， involving 12 283 patients. Results of Meta-analysis showed that the incidence of all grades and s evere AEs ，anemia，neutropenia， vomiting and alopecia as well as the incidence of thrombocytopenia，nausea and peripheral neuropathy in all grades of trial group were all significantly lower than control com group（P＜0.05）. There was no statistical significance in the incidence of termination of treatment ， death， severe thrombocytopenia， severe nausea and severe peripheral neuropathy or all grades and severe diarrhea between 2 groups（P＞0.05）. Subgroup analysis showed that the incidence of all grade and total severe AEs ，the incidence of anemia ，neutropenia，thrombocytopenia，clinically relevant symptoms （except for severe diarrhea），termination of treatment and death of patients receiving ICIs alone in trial group were significantly lower than control group（P＜0.05）. The incidence of ermination of treatment and death ，the incidence of nausea ，vomiting，diarrhea and alopecia in all grade ，severe diarrhea of patients receiving ICIs and chemotherapy in trial group were all significantly higher than control group （P＜0.05）. Sensitivity analysis supported the above results. Analyze publication bias results showed that the possibility of publication bias in this study was small. CONCLUSIONS ：For NSCLC patients ，the safety of ICIs is better than that of routine chemotherapy or placebo combined with routine chemotherapy in the treatment-related AEs ，hematologic toxicity and clinically relevant symptoms ；however，the risks of treatment discontinuation ，AEs-induced deaths ，and all-grade nausea ，vomiting， diarrhea，alopecia and severe diarrhea will be increased in the ICIs combined with routine chemotherapy.